Back
GlycoMimetics Vs. Dave Industry Stock Comparison
Sell
13
GLYC
GlycoMimetics
Last Price:
$0.27
Seasonality Move:
-9.63%
Buy
64
DAVE
Dave
Last Price:
$100.69
Seasonality Move:
-2.23%
Sell
13
GlycoMimetics (GLYC)
is a Sell
Is GlycoMimetics a Buy, Sell or Hold?
-
The current GlycoMimetics [GLYC] share price is $0.27. The Score for GLYC is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
-
GLYC is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
GLYC Stock Price Chart
What is GlycoMimetics's stock price today?
-
The GlycoMimetics share price today is $0.27Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GLYC is experiencing slight buying pressure.
DAVE Stock Price Chart
GLYC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0 | Buy |
Relative Strength Index (14 RSI): | 48.32 | Sell |
Chaikin Money Flow: | 113112 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.26 - 0.3) | Sell |
Bollinger Bands (100): | (0.19 - 0.35) | Buy |
DAVE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.23 | Buy |
Relative Strength Index (14 RSI): | 49.59 | Sell |
Chaikin Money Flow: | 296231 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (93.94 - 109.78) | Sell |
Bollinger Bands (100): | (54.87 - 102.95) | Buy |
GLYC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.29 | Sell |
20-day SMA: | 0.28 | Sell |
50-day SMA: | 0.26 | Buy |
200-day SMA: | 0.25 | Buy |
8-day EMA: | 0.28 | Sell |
20-day EMA: | 0.28 | Sell |
50-day EMA: | 0.28 | Sell |
200-day EMA: | 0.52 | Sell |
DAVE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 104.99 | Sell |
20-day SMA: | 104.31 | Sell |
50-day SMA: | 96.22 | Buy |
200-day SMA: | 58.36 | Buy |
8-day EMA: | 103 | Sell |
20-day EMA: | 102.6 | Sell |
50-day EMA: | 95.16 | Buy |
200-day EMA: | 65.4 | Buy |
GlycoMimetics Earnings Growth & GLYC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.01 per share, and a decrease next year of $0.00 per share.
Dave Earnings Growth & DAVE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.62 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.73 per share, and an increase next year of $1.09 per share.
GlycoMimetics Technical Analysis
Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | Feb 25 | Feb 26 | Feb 27 | Feb 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
13 | 14 | 18 | 19 | 20 | 21 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Dave Technical Analysis
Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | Feb 25 | Feb 26 | Feb 27 | Feb 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
13 | 14 | 18 | 19 | 20 | 21 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |